Femme et Homme
- | Pays :
- Germany
- | Organes : -
- | Spécialités : -
Extrait
This study is designed to assess the potential difference in Fasting Plasma Glucose (FPG) lowering efficacy between the two DPP-4 inhibitors vildagliptin and sitagliptin, both after a two weeks treatment on top of metformin.
Critère d'inclusion
- Diabetes Mellitus, Type 2